SARS-CoV-2 Spike glycoprotein, 1185-1193

Description:

This peptide is derived from severe acute respiratory syndrome coronavirus 2(SARS-Cov-2), Spike glycoprotein (Uniprot No: P0DTC2). Antigen Peptide RLNEVAKNL, probable allele specificity HLA-A*02:01, for stimulation of antigen-specific T cells in T cell assays.

Sequence:

RLNEVAKNL

General

References

Comments (0)

Name	SARS-CoV-2 Spike glycoprotein, 1185-1193
Category	COVID-19
One Letter Code	RLNEVAKNL
Three Letter Code	{ARG}{LEU}{ASN}{GLU}{VAL}{ALA}{LYS}{ASN}{LEU}
Molecular Weight	1056.220
Application	T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response

1. Grifoni, Alba, et al. "A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2." Cell host & microbe (2020).

2. Lee, Chloe Hyun-Jung, and Hashem Koohy. "In silico identification of vaccine targets for 2019-nCoV." F1000Research 9 (2020).